Get started
Author

Catharina M. Mulders‐Manders

Observed names: C M Mulders-Manders, C Mulders-Manders, C. M. Mulders-Manders, C.M. Mulders-Manders, Catharina M. Mulders-Manders, Catharina M Mulders-Manders, Catharina M. MULDERS-MANDERS, Catharina M. Manders, Catharina M. Mulders-Manders, Catharina Mulders-Manders, Mulders-Manders, C.M., Mulders-Manders, Catharina
ORCID: 0000-0002-8235-2629
Observed ORCID: 0000-0002-8235-2629
OpenAlex ID: A5043734734
Fever of Unknown Origin: the Value of FDG-PET/CT
2017 · Ilse J.E. Kouijzer, Catharina M. Mulders-Manders, et al. · Seminars in Nuclear Medicine · 143
PDF
Fever of unknown origin
2015 · Catharina Mulders-Manders, Anna Simon, et al. · Clinical Medicine · 133
PDF
Fever of Unknown Origin (FUO) – A Call for New Research Standards and Updated Clinical Management
2021 · William F. Wright, Catharina M. Mulders-Manders, et al. · The American Journal of Medicine · 74
Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?
2015 · C. M. Mulders-Manders, A. Simon · Seminars in Immunopathology · 62
PDF
Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts
2023 · Helen L Leavis, Paul L A van Daele, et al. · Lara D. Veeken · 49
PDF
Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature
2017 · Catharina M. Mulders-Manders, Marije C. Baas, et al. · Frontiers in Pharmacology · 34
PDF
Referral of patients with fever of unknown origin to an expertise center has high diagnostic and therapeutic value
2017 · C M Mulders-Manders, G Pietersz, et al. · QJM · 31
PDF
Long-term prognosis, treatment, and outcome of patients with fever of unknown origin in whom no diagnosis was made despite extensive investigation
2018 · Catharina M. Mulders-Manders, Celeste Engwerda, et al. · Medicine · 30
Rheumatologic diseases as the cause of fever of unknown origin
2016 · C.M. Mulders-Manders, A. Simon, et al. · Best Practice & Research Clinical Rheumatology · 30
Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin
2021 · Catharina M. MULDERS-MANDERS, Ilse J. KOUIJZER, et al. · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · 25
Recommendations for Updating Fever and Inflammation of Unknown Origin From a Modified Delphi Consensus Panel
2024 · William F Wright, Lauren Stelmash, et al. · Open Forum Infectious Diseases · 22
PDF
Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort
2023 · Marie Valérie E. Andriessen, G. Elizabeth Legger, et al. · Journal of Clinical Immunology · 22
Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis
2024 · Emil E. Vorsteveld, Caspar I. Van der Made, et al. · Clinical Immunology · 20
Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study
2018 · Catharina M. Mulders-Manders, Tim A. Kanters, et al. · Orphanet Journal of Rare Diseases · 19
PDF
Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype
2023 · Antoine Fayand, Margaux Cescato, et al. · Journal of Allergy and Clinical Immunology · 17
PDF
Update on imaging in fever and inflammation of unknown origin: focus on infectious disorders
2023 · Albrecht Betrains, Catharina M. Mulders-Manders, et al. · Clinical Microbiology and Infection · 16
Comparison of diagnostic spectrum between inflammation of unknown origin and fever of unknown origin: A systematic review and meta-analysis
2024 · Albrecht Betrains, Lien Moreel, et al. · European Journal of Internal Medicine · 14
PDF
Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency
2022 · Marcia A. Munoz, Oliver P. Skinner, et al. · Journal of Clinical Investigation · 13
PDF
OTULIN Haploinsufficiency-Related Fasciitis and Skin Necrosis Treated by TNF Inhibition
2023 · Rob J. W. Arts, Tristan J. van der Linden, et al. · Journal of Clinical Immunology · 12
PDF
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study
2023 · Merelijne A. Verschoof, Laura C. C. van Meenen, et al. · European Journal of Neurology · 12
PDF
Prevalence, risk factors, and long-term outcomes of cerebral ischemia in hospitalized COVID-19 patients – study rationale and protocol of the CORONIS study: A multicentre prospective cohort study
2022 · Theresa J van Lith, Wouter M Sluis, et al. · European Stroke Journal · 6
PDF
Novel genotypes, phenotypes, and triggers in humans with OTULIN haploinsufficiency
2025 · Tristan J. van der Linden, Rob J.W. Arts, et al. · Journal of Human Immunity · 5
PDF
Insights into the multifaceted role of interleukin-37 on human immune cell regulation
2024 · Lisa U. Teufel, Vasiliki Matzaraki, et al. · Clinical Immunology · 5
Development of a Consensus-Based List of Potential Quality Indicators for Fever and Inflammation of Unknown Origin
2024 · William F Wright, Albrecht Betrains, et al. · Open Forum Infectious Diseases · 3
PDF
Response to Jolobe: ‘Molecular diagnostics in FUO’
2018 · C M Mulders-Manders, A Simon, et al. · QJM · 3
Works count: 49
Citation count: 816
H-index: 16
I10-index: 20
Year
Topic
Type